Clinical trials · Bydgoszcz, Poland
Treatment-resistant depression, Alzheimer’s disease - new therapy trials
Promente conducts protocol-driven research in defined indications: depression, treatment-resistant depression (TRD), Alzheimer’s disease, mild cognitive impairment and other neurodegenerative disorders. Science, safety and commitment to the wellbeing of study participants and their families are our core values.
Expertise
Research focus
Promente focuses on defined clinical trial indications, including depression, treatment-resistant depression, Alzheimer’s disease, cognitive impairment, neurodegenerative disorders and selected psychedelic-assisted therapy protocols.
Treatment-resistant depression
Clinical trials for patients whose symptoms do not respond sufficiently to standard treatment pathways.
Psilocybin-assisted therapy research
Protocol-based clinical research under medical supervision, informed consent and strict eligibility criteria.
Alzheimer’s disease studies
Selected clinical research for early cognitive impairment and neurodegenerative disorders.
For patients
Participation in a clinical trial is always preceded by eligibility assessment, detailed information and informed consent.
No participation fee
Study-related medical procedures are covered within the clinical trial protocol.
Medical supervision
Participants are monitored by a clinical team according to approved study procedures.
Right to withdraw
Participants may withdraw from a clinical trial according to the informed consent process.
For sponsors and CROs
Clinical research site in Poland
We support psychiatric, neurological and neuropsychological clinical trial protocols in Bydgoszcz, combining patient recruitment, investigator experience and study coordination.
Clinical site informationE-E-A-T and medical context
Important medical note
Information on this website is educational and does not replace medical consultation or clinical trial eligibility assessment. Psychedelic-assisted therapy mentioned on this website refers to controlled clinical research protocols, not routine medical service availability.
Clinical trial participation depends on protocol-specific inclusion and exclusion criteria, medical assessment and documented informed consent.